Anemia hemolitică indusă de medicamente

1. Al Ghailani H.H., Al Alawi A.M., Al Hashim A.H. Contrast Media-Induced Immune Hemolytic Anemia. Cureus. 2021 Apr 16;13(4):e14522. https://doi.org/10.7759/cureus.14522

2. Arndt P., Garratty G., Isaak E.et al. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption. Transfusion. 2009;49:711-718. https://doi.org/10.1111/j.1537-2995.2008.02028.x

3. Arndt P.A. Drug-induced immune hemolytic anemia: the last 30 years of changes. Immunohematology. 2014;30:44-54.

https://doi.org/10.21307/immunohematology-2019-098

4. Baldwin C., Pandey J., Olarewaju O. Hemolytic anemia. Last update: June 6, 2022. Bookshelf ID: NBK558904PMID: 32644330

5. Chan Gomez J., Saleem T., Snyder S.et al. Drug-Induced Immune Hemolytic Anemia due to AmoxicillinClavulanate: A Case Report and Review. Cureus. 2020 Jun 17;12(6):e8666. https://doi.org/10.7759/cureus.8666

6. Esteves A., Teixeira da Silva F., Carvalho J.et al. Diclofenac-Induced Immune Hemolytic Anemia: A Case Report and Review of Literature. Cureus. 2021 Jan 25;13(1):e12903. https://doi.org/10.7759/cureus.12903

7. Frieder J., Mouabbi J.A., Zein R., Hadid T. Autoimmune hemolytic anemia associated with trimethoprimsulfamethoxazole use. Am J Health Syst Pharm. 2017 Jun 15;74(12):894-897. https://doi.org/10.2146/ajhp160203

8. Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009:73-9. https://doi.org/10.1182/asheducation-2009.1.73

9. Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Reviews. 2010; 24:143-150. https://doi.org/10.1016/j.blre.2010.06.004

10. Hernández M.A., Roldán T.M.D., Herrera A.L., MartínezS.L.M. Hemolytic anemia associated with antimicrobial drugs. Enf Infec Microbiol 2018; 38 (3), 81-85.

11. Hill Q.A., Stamps R., Massey E. et al. British Society for Haematology Guidelines. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br.J. Haematol. 2017 Apr;177(2):208-220. https://doi.org/10.1111/bjh.14654

12. Karunathilaka H.G.C.S., Chandrasiri D.P., Ranasinghe P.et al. Co-Amoxiclav induced immune haemolytic anaemia: a case report. Case Rep Hematol. 2020;2020:9841097.

13. Kirkiz S, Yarali N, Arman Bilir O, Tunc B. Metform- in-induced hemolytic anemia. Med Princ Pract. 2014;23(2):183-5. Epub 2013 Nov 27. https://doi.org/10.1159/000356149

14. Leger R.M., Arndt P.A., Garratty G. How we investigate drug-induced immune hemolytic anemia. Immuno- hematology. 2014;30:85-94.

https://doi.org/10.21307/immunohematology-2019-102

15. Leicht H.B., Weinig E., Mayer B. et al. Ceftriaxoneinduced hemolytic anemia with severe renal failure: a case report and review of literature. BMC Pharmacol Toxicol . 2018;19:67. https://doi.org/10.1186/s40360-018-0257-7

16. Mayer B., Bartolmas T., Yurek S., Salama A. Variability of findings in drug-induced immune Haemolytic Anaemia: experience over 20 years in a single Centre. Transfus Med Hemother. 2015;42:333-339. https://doi.org/10.1159/000440673

17. Mause E., Selim M., Velagapudi M. Cefazolin-induced hemolytic anemia: a case report and systematic review of literature. Eur J Med Res. 2021 Nov 24;26(1):133. https://doi.org/10.1186/s40001-021-00604-9

18. Oswald G., Alzoubi K., Abed M., Lang F. Stimulation of suicidal erythrocyte death by ribavirin. Basic Clin Pharmacol Toxicol. 2014;114:311-317. https://doi.org/10.1111/bcpt.12165

19. Packer CD, Hornick TR, Augustine SA. Fatal hemolytic anemia associated with metformin: a case report. J Med Case Rep. 2008 Sep 10;2:300. https://doi.org/10.1186/1752-1947-2-300

20. Palmer D., Seviar D. How to approach haemolysis: Haemolytic anaemia for the general physician. Clin Med (Lond). 2022 May;22(3):210-213. https://doi.org/10.7861/clinmed.2022-0142

21. Pecker L.H., Timsar A., Pary P.P.et al. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma. Pediatr Blood Cancer. 2016;63:1852-1855. https://doi.org/10.1002/pbc.26101

22. Pipet A., Veyrac G., Wessel F. et al. A statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross-reactivities. Clin Exp Allergy. 2011;41(11):1602-1608. https://doi.org/10.1111/j.1365-2222.2011.03846.x

23. Renard D., Rosselet A. Drug-induced hemolytic anemia: Pharmacological aspects. Transfus Clin Biol. 2017 Sep;24(3):110-114. https://doi.org/10.1016/j.tracli.2017.05.013

24. Roy Choudhury A., Gadaga C., Moodley L., Moodley A. Metformin-Induced Hemolysis in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Presenting With Concurrent Idiopathic Steven-Johnson Syndrome/Toxic Epidermal Necrolysis. Cureus. 2021 Oct 5;13(10): e18506. https://doi.org/10.7759/cureus.18506

25. Salama A., Mayer B. Diagnostic pitfalls of druginduced immune hemolytic anemia. Immunohema- tology. 2014;30:80-84.

https://doi.org/10.21307/immunohematology-2019-101

26. Salama A. Clinically and/or serologically misleading findings in autoimmune haemolytic anaemias. Trans- fus Med Hemother. 2015;42 https://doi.org/10.1159/000438960

27. Shenoy E.S., Macy E., Rowe T., Blumenthal K.G. Evaluation and management of penicillin allergy: a review. JAMA. 2019;321(2):188-199. https://doi.org/10.1001/jama.2018.19283

28. Singh A., Singhania N., Sharma A.et al. CeftriaxoneInduced Immune Hemolytic Anemia. Cureus. 2020 Jun 17;12(6):e8660. https://doi.org/10.7759/cureus.8660

29. Stevens-Cohen P., Zaghi F., Zhu L. A Rare Case of Hydrochlorothiazide-Induced Hemolytic Anemia. Cureus. 2021 Aug 26;13(8): e17453. https://doi.org/10.7759/cureus.17453

30. Wu Y., Wu Y., Yang Y.etal. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascu- lar Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immuno- logic Protein Adsorption. Front Immunol. 2021 Dec 22;12:698541. https://doi.org/10.3389/fimmu.2021.698541

31. Udristioiu A., Iliescu R. G., Cojocaru M. Anemia hemolitică indusă de medicamente. Prezentare de caz. Med. Con. 2016 March, 11(1). 81-86.